These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27402300)

  • 1. Frequency, type and treatment of fungal pathogens in toenail onychomycosis in the central Alpine region of South Tyrol, northern Italy - a 10-year retrospective study from 2004 to 2013.
    Gasser J; Pagani E; Vittadello F; Nobile C; Zampieri P; Eisendle K
    Mycoses; 2016 Dec; 59(12):760-764. PubMed ID: 27402300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and mycological features of onychomycosis in central Tunisia: a 22 years retrospective study (1986-2007).
    Dhib I; Fathallah A; Yaacoub A; Zemni R; Gaha R; Said MB
    Mycoses; 2013 May; 56(3):273-80. PubMed ID: 23094998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of onychomycosis in Crete, Greece: a 12-year study.
    Maraki S; Mavromanolaki VE
    Mycoses; 2016 Dec; 59(12):798-802. PubMed ID: 27432461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective study of onychomycosis in Italy: 1985-2000.
    Romano C; Gianni C; Difonzo EM
    Mycoses; 2005 Jan; 48(1):42-4. PubMed ID: 15679665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological and mycological data of onychomycosis in Goiania, Brazil.
    Souza LK; Fernandes OF; Passos XS; Costa CR; Lemos JA; Silva MR
    Mycoses; 2010 Jan; 53(1):68-71. PubMed ID: 19207842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Causative agents of onychomycosis--a retrospective study].
    Mügge C; Haustein UF; Nenoff P
    J Dtsch Dermatol Ges; 2006 Mar; 4(3):218-28. PubMed ID: 16626318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toenail onychomycosis in Estonia.
    Järv H; Naaber P; Kaur S; Eisen M; Silm H
    Mycoses; 2004 Feb; 47(1-2):57-61. PubMed ID: 14998401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of the DermaGenius® Nail real-time PCR assay for the detection of dermatophytes and Candida albicans in nails.
    Hayette MP; Seidel L; Adjetey C; Darfouf R; Wéry M; Boreux R; Sacheli R; Melin P; Arrese J
    Med Mycol; 2019 Apr; 57(3):277-283. PubMed ID: 29762721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Causative agents of superficial mycoses isolated in Dakar, Senegal: Retrospective study from 2011 to 2015].
    Diongue K; Diallo MA; Ndiaye M; Badiane AS; Seck MC; Diop A; Ndiaye YD; Ndiaye D
    J Mycol Med; 2016 Dec; 26(4):368-376. PubMed ID: 27592054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onychomycosis in eastern Nepal.
    Agarwalla A; Agrawal S; Khanal B
    Nepal Med Coll J; 2006 Dec; 8(4):215-9. PubMed ID: 17357634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onychomycosis in Tehran, Iran: prevailing fungi and treatment with itraconazole.
    Khosravi AR; Mansouri P
    Mycopathologia; 2001; 150(1):9-13. PubMed ID: 11392568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatophyte and non-dermatophyte onychomycosis in Singapore.
    Lim JT; Chua HC; Goh CL
    Australas J Dermatol; 1992; 33(3):159-63. PubMed ID: 1303077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onychomycosis: modern diagnostic and treatment approaches.
    Tchernev G; Penev PK; Nenoff P; Zisova LG; Cardoso JC; Taneva T; Ginter-Hanselmayer G; Ananiev J; Gulubova M; Hristova R; Nocheva D; Guarneri C; Martino G; Kanazawa N
    Wien Med Wochenschr; 2013 Jan; 163(1-2):1-12. PubMed ID: 23053563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular identification and antifungal susceptibility of clinical fungal isolates from onychomycosis (uncommon and emerging species).
    Haghani I; Shams-Ghahfarokhi M; Dalimi Asl A; Shokohi T; Hedayati MT
    Mycoses; 2019 Feb; 62(2):128-143. PubMed ID: 30255665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Onychomycosis in Chinese Mainland: A 30-year Retrospective Study.
    Song G; Zhang M; Liu W; Liang G
    Mycopathologia; 2022 Aug; 187(4):323-331. PubMed ID: 35819711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onychomycosis in Israel: epidemiological aspects.
    Segal R; Shemer A; Hochberg M; Keness Y; Shvarzman R; Mandelblat M; Frenkel M; Segal E
    Mycoses; 2015 Mar; 58(3):133-9. PubMed ID: 25590832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of onychomycosis in Serbia: a laboratory-based survey and risk factor identification.
    Dubljanin E; Džamić A; Vujčić I; Grujičić SŠ; Arsenijević VA; Mitrović S; Čalovski IČ
    Mycoses; 2017 Jan; 60(1):25-32. PubMed ID: 27469902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increasing frequency of onychomycoses--is there a change in the spectrum of infectious agents?].
    Ginter G; Rieger E; Heigl K; Propst E
    Mycoses; 1996; 39 Suppl 1():118-22. PubMed ID: 8767283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of non-dermatophyte moulds and yeasts in onychomycosis.
    Ellis DH; Marley JE; Watson AB; Williams TG
    Dermatology; 1997; 194 Suppl 1():40-2. PubMed ID: 9154401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onychomycosis in São Paulo, Brazil.
    Godoy-Martinez P; Nunes FG; Tomimori-Yamashita J; Urrutia M; Zaror L; Silva V; Fischman O
    Mycopathologia; 2009 Sep; 168(3):111-6. PubMed ID: 19424818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.